Approved indication: cystic fibrosis

被引：3

|

作者：

不详

机构：

来源：

AUSTRALIAN PRESCRIBER | 2019年 / 42卷 / 05期

关键词：

TEZACAFTOR-IVACAFTOR;

D O I：

10.18773/austprescr.2019.060

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：174 / 175

页数：2

相关论文

共 50 条

[1] Approved indication: cystic fibrosis
不详
[J]. AUSTRALIAN PRESCRIBER, 2021, 44 (04) : 137 - 138
[2] Cystic fibrosis drug approved
Brainard, Jeffrey
[J]. SCIENCE, 2019, 366 (6465) : 554 - 554
[3] Ivacaftor approved for cystic fibrosis
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (05) : 363 - 363
[4] CYSTIC-FIBROSIS TRIALS APPROVED
THOMPSON, L
[J]. SCIENCE, 1992, 258 (5089) : 1728 - 1728
[5] CYSTIC-FIBROSIS - ACIDIFICATION INDICATION
WELSH, MJ
[J]. NATURE, 1991, 352 (6330) : 23 - 24
[6] BIOENGINEERED CYSTIC-FIBROSIS DRUG APPROVED
THAYER, A
[J]. CHEMICAL & ENGINEERING NEWS, 1994, 72 (02) : 5 - 5
[7] Indication for lung transplantation in advanced cystic fibrosis
Speich, R
Boehler, A
Spiliopoulos, A
Weder, W
Nicod, LP
[J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (39) : 1352 - 1360
[8] First Biosimilar of Inhalation Solution for Cystic Fibrosis Treatment Approved
不详
[J]. BIOPHARM INTERNATIONAL, 2019, 32 (11) : 13 - 13
[9] DEVELOPMENT OF A DRUG PRICE INDEX FOR APPROVED CYSTIC FIBROSIS TREATMENTS
Seo, D.
Levy, J.
Young, D.
Conti, R.
Mattingly, T. J.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S157 - S157
[10] Bronchitol has been approved in the EU for the treatment of cystic fibrosis
Attwood, Claire
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (03) : 249 - 249

← 1 2 3 4 5 →